Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cation exchange chromatography removes FXIa from a 10% intravenous immunoglobulin preparation. | Front Cardiovasc Med | 2023 | 38075963 | PubTator, text mining | PubMed |
| Pregnancy, childbirth and neonatal outcomes of women with rare inherited coagulation disorders. | Obstet Med | 2023 | 38074209 | PubTator, text mining | PubMed |
| Extracellular vesicles in venous thromboembolism and pulmonary hypertension. | J Nanobiotechnology | 2023 | 38037042 | PubTator, text mining | PubMed |
| Association between Blood Group and Change in Coagulation Factors in Plasma Preparations for Transfusion Purpose at Kisii Teaching and Referral Hospital. | Adv Hematol | 2023 | 38029003 | PubTator, text mining | PubMed |
| Enhancement of recombinant adeno-associated virus activity by improved stoichiometry and homogeneity of capsid protein assembly. | Mol Ther Methods Clin Dev | 2023 | 38027055 | PubTator, text mining | PubMed |
| Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles. | Bioeng Transl Med | 2023 | 38023707 | PubTator, text mining | PubMed |
| Cerebral Venous Thrombosis during Thyrotoxicosis: Case Report and Literature Update. | J Pers Med | 2023 | 38003871 | PubTator, text mining | PubMed |
| Identification of 13 Novel Loci in a Genome-Wide Association Study on Taiwanese with Hepatocellular Carcinoma. | Int J Mol Sci | 2023 | 38003606 | PubTator, text mining | PubMed |
| Factor XI in Carriers of Antiphospholipid Antibodies: Elevated Levels Associated with Symptomatic Thrombotic Cases, While Low Levels Linked to Asymptomatic Cases. | Int J Mol Sci | 2023 | 38003459 | PubTator, text mining | PubMed |
| Serum Reactive Antibodies against the N-Methyl-D-Aspartate Receptor NR2 Subunit-Could They Act as Potential Biomarkers? | Int J Mol Sci | 2023 | 38003360 | PubTator, text mining | PubMed |
| Multifaceted Tissue-Protective Functions of Polyvalent Immunoglobulin Preparations in Severe Infections-Interactions with Neutrophils, Complement, and Coagulation Pathways. | Biomedicines | 2023 | 38002022 | PubTator, text mining | PubMed |
| Platelet factor 4 limits neutrophil extracellular trap- and cell-free DNA-induced thrombogenicity and endothelial injury. | JCI Insight | 2023 | 37991024 | PubTator, text mining | PubMed |
| Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies. | Sci Rep | 2023 | 37985892 | PubTator, text mining | PubMed |
| RhoA suppresses pseudorabies virus replication in vitro. | Virol J | 2023 | 37968757 | PubTator, text mining | PubMed |
| Acquired Clotting Factor Deficits During Treatment with Asparaginase in an Institutional Cohort. | J Blood Med | 2023 | 37965639 | PubTator, text mining | PubMed |
| Systems genetics approaches for understanding complex traits with relevance for human disease. | Elife | 2023 | 37962168 | PubTator, text mining | PubMed |
| Independent and Interactive Roles of Immunity and Metabolism in Aortic Dissection. | Int J Mol Sci | 2023 | 37958896 | PubTator, text mining | PubMed |
| Novel strategies in antithrombotic therapy: targeting thrombosis while preserving hemostasis. | Front Cardiovasc Med | 2023 | 37937289 | PubTator, text mining | PubMed |
Computational identification and clinical validation of a novel risk signature based on coagulation-related lncRNAs for predicting prognosis, immunotherapy response, and chemosensitivity in colorectal cancer patients. | Front Immunol | 2023 | 37928532 | PubTator, text mining | PubMed |
| Editorial: Kallikrein-kinin system: insights into a multifunctional system. | Front Physiol | 2023 | 37908332 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=16